225 related articles for article (PubMed ID: 7975265)
1. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
Brokaw JL; Yee CL; Münger K
Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
[TBL] [Abstract][Full Text] [Related]
2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
4. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
5. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
[TBL] [Abstract][Full Text] [Related]
6. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
[TBL] [Abstract][Full Text] [Related]
8. Repression of p53 transcriptional activity by the HPV E7 proteins.
Massimi P; Banks L
Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
[TBL] [Abstract][Full Text] [Related]
9. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
10. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
11. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
Avvakumov N; Torchia J; Mymryk JS
Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
[TBL] [Abstract][Full Text] [Related]
13. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
Banks L; Edmonds C; Vousden KH
Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
[TBL] [Abstract][Full Text] [Related]
14. Chaperone holdase activity of human papillomavirus E7 oncoprotein.
Alonso LG; Smal C; Garcia-Alai MM; Chemes L; Salame M; de Prat-Gay G
Biochemistry; 2006 Jan; 45(3):657-67. PubMed ID: 16411741
[TBL] [Abstract][Full Text] [Related]
15. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
Prathapam T; Kühne C; Banks L
Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
18. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.
Moran E
Nature; 1988 Jul; 334(6178):168-70. PubMed ID: 2968523
[TBL] [Abstract][Full Text] [Related]
19. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
[TBL] [Abstract][Full Text] [Related]
20. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
Routes JM; Ryan S; Li H; Steinke J; Cook JL
Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
